| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.06 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |